Proprietary AI analyst is now available

Delko Valuation Multiples

Discover revenue and EBITDA valuation multiples for Delko and similar public comparables like Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma and more.

Delko Overview

About Delko

Delko SA is engaged in the wholesale distribution of household chemistry products, cosmetics and personal care products in Poland.


Founded

1995

HQ

Poland

Employees

897

Financials (FY)

Revenue: $213M
EBITDA: $7M

EV

$41M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Delko Financials

Delko reported last fiscal year revenue of $213M and EBITDA of $7M.

In the same fiscal year, Delko generated $47M in gross profit, $7M in EBITDA, and $789K in net income.


Delko P&L

In the most recent fiscal year, Delko reported revenue of $213M and EBITDA of $7M.

Delko is profitable as of last fiscal year, with gross margin of 22%, EBITDA margin of 3%, and net margin of 0%.

See analyst estimates for Delko
Last FY202320242025202620272028
Revenue$213M$367M$241M$213M
Gross Profit$47M$78M$51M$47M
Gross Margin22%21%21%22%
EBITDA$7M$21M$11M$7M
EBITDA Margin3%6%5%3%
EBIT Margin1%4%2%1%
Net Profit$789K$11M$4M$789K
Net Margin0%3%2%0%
Net Debt$7M---

Financial data powered by Morningstar, Inc.

Delko Stock Performance

Delko has current market cap of $19M, and enterprise value of $41M.

Market Cap Evolution


Delko's stock price is $1.61.

Delko share price decreased by 2.6% in the last 30 days, and by 11.4% in the last year.

Delko has an EPS (earnings per share) of $0.07.

See more trading valuation data for Delko
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$41M$19M0.0%-2.6%-6.9%-11.4%$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Delko Valuation Multiples

Delko trades at 0.2x EV/Revenue multiple, and 5.6x EV/EBITDA.

See NTM and 2027E valuation multiples for Delko

Delko Financial Valuation Multiples

As of June 14, 2026, Delko has market cap of $19M and EV of $41M.

Delko has a P/E ratio of 24.4x.

Last FY202320242025202620272028
EV/Revenue0.2x0.1x0.2x0.2x
EV/EBITDA5.6x2.0x3.8x5.6x
EV/EBIT23.1x2.9x8.0x23.1x
EV/Gross Profit0.9x0.5x0.8x0.9x
P/E24.4x1.8x4.6x24.4x
EV/FCF6.8x4.6x4.6x6.8x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Delko Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Delko Margins & Growth Rates

In the most recent fiscal year, Delko reported gross margin of 22%, EBITDA margin of 3%, and net margin of 0%.

See estimated margins and future growth rates for Delko

Delko Margins

Last FY20242025202720282029
Gross Margin22%21%22%
EBITDA Margin3%5%3%
EBIT Margin1%2%1%
Net Margin0%2%0%
FCF Margin3%4%3%

Delko Growth Rates

23/2424/2526/2727/2828/29
Revenue Growth(34%)(11%)
Gross Profit Growth(35%)(8%)
EBITDA Growth(48%)(33%)
EBIT Growth(64%)(65%)
Net Profit Growth(62%)(81%)
FCF Growth(1%)(32%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Delko Operational KPIs

Delko's revenue per employee in the last FY averaged $0.2M, while opex per employee averaged $0.1M for the same period.

Access forward-looking KPIs for Delko
Last FY202320242025202620272028
Revenue per Employee$0.2M---
Opex per Employee$0.1M---
Opex to Revenue21%17%19%21%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Delko Competitors

Delko competitors include Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma, Big Tree Cloud Holdings, Skin Elements, Mediterra, Lavena - Shumen, Clemondo Group and 4Mass.

Most Delko public comparables operate across Health & Beauty and Home Care.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Promisia Healthcare4.4x-9.2x-
EZZ Life Science0.2x0.2x1.1x-
Natural Health Trends(0.0x)-0.6x-
Cosma3.6x-(20.9x)-
Big Tree Cloud Holdings8.3x-(0.7x)-
Skin Elements36.8x-(10.6x)-
Mediterra----
Lavena - Shumen0.8x-5.2x-

This data is available for Pro users. Sign up to see all Delko competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Delko

When was Delko founded?Delko was founded in 1995.
Where is Delko headquartered?Delko is headquartered in Poland.
How many employees does Delko have?As of today, Delko has over 897 employees.
Is Delko publicly listed?Yes, Delko is a public company listed on Warsaw Stock Exchange.
What is the stock symbol of Delko?Delko trades under DEL ticker.
When did Delko go public?Delko went public in 2009.
Who are competitors of Delko?Delko main competitors include Promisia Healthcare, EZZ Life Science, Natural Health Trends, Cosma, Big Tree Cloud Holdings, Skin Elements, Mediterra, Lavena - Shumen, Clemondo Group, 4Mass.
What is the current market cap of Delko?Delko's current market cap is $19M.
What is the current revenue of Delko?Delko's last fiscal year revenue is $213M.
What is the current EV/Revenue multiple of Delko?Current revenue multiple of Delko is 0.2x.
Is Delko profitable?No, Delko is not profitable.
How many companies Delko has acquired to date?Delko hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Delko has invested to date?Delko hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Delko

Lists including Delko

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial